About the journal
Cancer Letters is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,100 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1872-7980 · 0304-3835
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 4,100 USD
- Declared peer-review model
- peer_review
Index listings
- MEDLINE · 1975-01-01
- PUBMED · 1985-09-15
- Indexing
- MEDLINE · PUBMED
- APC
- 4,100 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 149 days received→accepted — computed from PubMed (n=95)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
19194
Last recorded publication year
2026
h-index
268
i10-index
13213
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 89%
- ORCID iDs in current deposits
- 74%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 7600053
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Human auditory perception and evaluation
Show all subjects (50)
- RNA modifications and cancer
- RNA modifications and cancer
- Carcinogens and Genotoxicity Assessment
- Carcinogens and Genotoxicity Assessment
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Genomics, phytochemicals, and oxidative stress
- Genomics, phytochemicals, and oxidative stress
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Cancer-related gene regulation
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Cancer-related gene regulation
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ